Deafness: Clinical Trials

2 trials for Deafness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2
Phase 21Unknown 1

Follow Deafness: new trials by email Literature Review of Deafness trials Research Report on Deafness

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BF844 Safety and Pharmacokinetic Study in Healthy Volunteers
BF844 - Usher Syndrome Type 3
Phase 1UnknownEyeXCel Pty. Ltd.762024-09-092024-09-19
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
N-Acetyl Cysteine - Ototoxic Hearing Loss
Phase 1 / Phase 2UnknownSunnybrook Health Sciences Centre802020-02-262023-09-06

Narrower conditions

Ear Diseases (1)  ·  Hearing Loss (1)  ·  Hearing Loss, Sensorineural (1)  ·  Usher Syndromes (1)

Broader conditions

Hearing Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)  ·  Abnormalities, Multiple (1)  ·  Blindness (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Deaf-Blind Disorders (1)  ·  Ear Diseases (1)  ·  Eye Diseases (1)

Interventions

Acetylcysteine (1)

Sponsors

EyeXCel Pty. Ltd. (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

Australia (1)  ·  Canada (1)

Top investigators

Benedict Tan, MBBS, FRACP (1)  ·  Trung N Le (1)